© The Author 2007. Published by Oxford University Press.
CORRESPONDENCE |
Re: p27Kip1 and Cyclin E Expression and Breast Cancer Survival After Treatment With Adjuvant Chemotherapy
Affiliations of authors: Departments of Chemical Endocrinology (PNS, FCGJS) and Medical Oncology (PHDM), Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
Correspondence to: Paul N. Span, PhD, 479 Department of Chemical Endocrinology, Radboud University Nijmegen Center Nijmegen, PO Box 9101, 6500 HB Nijmegen, The Netherlands (e-mail: p.span@ace.umcn.nl).
| The first 10% of the full text of this article appears below. |
Porter et al. (1) recently described their evaluation of the association between survival and p27Kip1and cyclin E immunohistochemical staining on tissue microarrays from 2123 breast cancer patients treated with doxorubicin and cyclophosphamide. Although p27Kip1 was statistically
Related Article in JNCI
![]()
CiteULike
Connotea
Del.icio.us What's this?
J Natl Cancer Inst 2006 98: 1723-1731.